Please rate the following faculty:
Dr. Judy Garber (DFCI) – Genetic Testing Comes of Age in Breast and Ovarian Cancer
Dr. Tiffany Traina (MSKCC) – Triple Negative Breast Cancer: Have we made any progress?
Dr. Sudhir Gupta (UCI) – COVID-19 and Cancer: Virus to Vaccine
Dr. William Audeh (Agendia) - The Long and Winding Road of PARP Inhibitor Development
Dr. Mark Robson (MSKCC) - Managing Patients with Moderate Penetrance Mutations
Dr. Maria Theodoulou (NYOH) - The Clinical Seasons of HER-2 neu Positive Breast Cancer
Dr. Chau Dang (MSKCC) - Updates in the Treatment of HER-2 Positive Breast Cancer
Dr. Claudine Isaacs (GU) - Updates on Endocrine Therapy in Early Stage Breast Cancer
Dr. Leslie Boyd (NYU Langone) - Therapeutic HPV Vaccines: On the Horizon